Thus, a gain-of-function approach using mice with a constitutively active STAT3 protein in type I collagen-expressing fibroblasts suggests a critical role of STAT3-related signaling in this subset of cells to drive tumor growth by inducing the enhanced proliferation of tumor epithelial cells in inflammation-associated CRC models. The gene discussed is STAT3; the disease is colorectal carcinoma.